id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-276938-hv2ttwr8	Artru, Florent	Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis	2020-07-07		.txt	text/plain	1315	88	51	We report on a patient with coronavirus disease 2019 (COVID-19) and decompensated cirrhosis who experienced a favourable outcome of severe immune thrombocytopaenic purpura (ITP) after administration of intravenous immunoglobulin and high-dose dexamethasone. We report on a patient with coronavirus disease 2019 (COVID-19) and decompensated cirrhosis who experienced a favourable outcome of severe immune thrombocytopaenic purpura (ITP) after administration of intravenous immunoglobulin and high-dose dexamethasone. Published data suggest that poor outcome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is related to an excessive inflammatory reaction. Laboratory tests performed over the next days showed a rapid decrease of platelet count from baseline values around 70 g/L (chronic moderate thrombocytopaenia due to liver disease and hypersplenism) to a nadir of 1 x10 9 /L (figure 1). ► Treatment of ITP in the context of coronavirus disease 2019 (COVID-19) with high-dose dexamethasone and intravenous immunoglobulin (IVIG) appears to be effective.	./cache/cord-276938-hv2ttwr8.txt	./txt/cord-276938-hv2ttwr8.txt